tm logo

Monitor this mark

View On USPTO

URIXMY
Live/Registered
REGISTERED

on 06 Feb 2024

Last Applicant/ Owned by

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89

Rixensart

BE

B-1330

Serial Number

97317607 filed on 17th Mar 2022

Registration Number

7296583 registered on 06th Feb 2024

in the Principal Register

Correspondent Address

Christopher M. Hanes

Christopher M. Hanes

410 Blackwell Street

Legal Brand Protection

Durham, NC, 27701

Filing Basis

1. intent to use

Disclaimer

NO DATA

URIXMY

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Vaccines

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Vaccines

Mark Details

Serial Number

No 97317607

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84161748

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
06th Feb 2024REGISTERED-PRINCIPAL REGISTER
06th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
21st Nov 2023PUBLISHED FOR OPPOSITION
21st Nov 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01st Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Oct 2023NOTICE OF ALLOWANCE CANCELLED
18th Oct 2023CASE RETURNED TO EXAMINATION
10th Oct 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
10th Oct 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
04th Oct 2023ASSIGNED TO PETITION STAFF